Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation

Treatment of brain tumors is challenging since the blood–brain tumor barrier prevents chemotherapy drugs from reaching the tumor site in sufficient concentrations. Nanomedicines have great potential for therapy of brain disorders but are still uncommon in clinical use despite decades of research and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundy, David J., Nguyễn, Helen, Hsieh, Patrick C. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399364/
https://www.ncbi.nlm.nih.gov/pubmed/34452156
http://dx.doi.org/10.3390/pharmaceutics13081193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399364/
https://www.ncbi.nlm.nih.gov/pubmed/34452156
http://dx.doi.org/10.3390/pharmaceutics13081193

Ejemplares similares